EAN 2024: Real-World Data Show Ofatumumab Reduces Multiple Sclerosis Disability, Relapse
Favorable safety profile also found, with no serious adverse events reported
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.